Last $34.85 USD
Change Today -1.17 / -3.25%
Volume 329.3K
PODD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles T. Liamos

Director of Advanced Technology and Director, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 51 board members in 6 different organizations across 9 different industries.

See Board Relationships
54$2,246,566
As of Fiscal Year 2013

Background*

Mr. Charles T. Liamos, also known as Charlie, serves as a Partner of MedVenture Associates. Mr. Liamos has been Director of Advanced Technology at Insulet Corporation since January 2014. Mr. Liamos served as the Chief Operating Officer of Insulet Corporation from 2010 to January 21, 2014. He joined MedVenture Associates in September 2006 as Executive Residence. He has more than 10 years of experience of finance and operations’ leadership positions and more than 11 years ...

Read Full Background

Corporate Headquarters*

9 Oak Park Drive
Bedford, Massachusetts 01730

United States

Phone: 781-457-5000
Fax: 781-457-5011

Board Members Memberships*

Director
Former Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Director, Executive Officer of TheraSense Canada, Executive Officer of TheraSense UK Limited and Executive Officer of TheraSense Sales Corp
Director
Director
Former Director
Director
Director
Director
2005-Present
Director of Advanced Technology and Director

Education*

BS
The University of Vermont

Other Affiliations*

Annual Compensation*

Salary$376,885
Total Annual Compensation$376,885

Stock Options*

Restricted Stock Awards$1,474,200
All Other Compensation$7,650
Exercised Options113,808
Exercised Options Value$2,573,304
Exercisable Options83,037
Exercisable Options Value$1,727,187
Unexercisable Options85,000
Unexercisable Options Value$1,628,700
Total Value of Options$5,929,191
Total Number of Options281,845

Total Compensation*

Total Annual Cash Compensation$563,120
Total Short Term Compensation$376,885
Other Long Term Compensation$1,481,850
Total Calculated Compensation$2,246,566
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PODD:US $34.85 USD -1.17

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Terrance H. Gregg Chief Executive Officer and Director
DexCom, Inc.
$420.0K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.4M GBP
Alan D. Shortall Chairman, Chief Executive Officer, Member of Strategic Partnerships Committee and Chief Executive Officer of UMSL
Unilife Corporation
$630.0K
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$472.1K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULET CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.